An Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors

Conditions:   Hepatocellular Carcinoma;   Cholangiocarcinoma;   Gastric Cancer;   Esophageal Cancer;   Colorectal Cancer
Intervention:   Drug: ZSP1241
Sponsor:   Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Not yet recruiting

https://ift.tt/2PjtEmu